Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Health King Enterprise & Balanceuticals Group, Inc.
WARNING LETTER
•Health King Enterprise & Balanceuticals Group, Inc.•June 30, 2013

Health King Enterprise & Balanceuticals Group, Inc. – FDA Warning Letter, Jun 30, 2013

Record Details

The FDA issued a Warning Letter to Health King Enterprise & Balanceuticals Group, Inc. after reviewing their websites, www.healthkingenterprise.com and www.balanceuticals.com, in June 2013. The FDA determined that five products—"Sugar Balancer," "Blood Pressure Balance," "Bio-Defender," "AlcohLiver Fix," and "Super Reishi Essence"—were promoted for conditions that cause them to be unapproved new drugs under Section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act).

The websites made claims indicating the products were intended for the cure, mitigation, treatment, or prevention of disease, such as "Sugar Balancer" for diabetes, "Blood Pressure Balance" for hypertension and coronary disease, "Bio-Defender" for viral, bacterial, and fungal infections including HIV and anthrax, "AlcohLiver Fix" for hepatitis and liver damage, and "Super Reishi Essence" for cancer and neurasthenia.

These products are considered "new drugs" under Section 201(p) of the Act because they are not generally recognized as safe and effective for their claimed uses and lack prior FDA approval, violating Section 505(a) and 301(d). Furthermore, the products are misbranded under Section 502(f)(1) because they address conditions not amenable to self-diagnosis and treatment, meaning

Company
Health King Enterprise & Balanceuticals Group, Inc.
Inspection date
June 30, 2013
Product type
Drugs
Office
Chicago District Office
Person
  • Scott J. Macintire
View Company Profile

ID · 6618111d-2bff-4404-88f2-4d0a10cd7f35

Violation Codes5
21 U.S.C. 321(g)(1)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Health King Enterprise & Balanceuticals Group, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.